Current filters:

Sanofi Pasteur

26 to 35 of 56 results

Clinical trial results indicate advance in Dengue vaccine research by Sanofi Pasteur


The Dengue Vaccine Initiative (DVI) has welcomed new clinical trial results that reveal progress in developing…

CYD-TDVSanofiSanofi Pasteur

Sanofi Pasteur's dengue vaccine proves effective and safe; FDA identifies cGMP deviations


French drug major Sanofi (Euronext: SAN) vaccines subsidiary Sanofi Pasteur sais this morning that its…

PharmaceuticalRegulationResearchSanofiSanofi PasteurTropical diseasesVaccines

Sanofi Pasteur starts shipping Fluzone in USA for 2012-2013 flu season


The first lots of Fluzone vaccine have began shipping to US health care providers following Food and…

Anti-viralsFluzoneMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

US consumer groups call on FTC to investigate anti-competitive practices of vaccine makers


In the USA, Citizens for Responsibility and Ethics in Washington (CREW), the National Legislative Association…

CervarixGardasilMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalPricingSanofiSanofi PasteurVaccines

Vivalis opens new lab for antibody discovery; posts 112% revenue hike


French biotech firm Vivalis (NNYSE Euronext: VLS) says it has opened a new facility for partnered VIVA|Screen…

BiotechnologyEuropeFinancialResearchSanofi PasteurVivalis

Sanofi Pasteur and Vivalis extend MAb accord


French biopharma company Vivalis (NYSE Euronext: VLS) says it has extended the agreement signed in 2010…

Antibiotics and Infectious diseasesLicensingPharmaceuticalResearchSanofiSanofi PasteurVivalis

Sanofi Pasteur enters $3 billion acne treatment market in deal with UC San Diego


Moving into a new therapeutic sector, Sanofi Pasteur, the vaccines division of French drug major Sanofi…

LicensingPharmaceuticalResearchSanofiSanofi PasteurVaccines

26 to 35 of 56 results

Back to top